IP licensing and business: Sept. 11-Sept. 24
Licensing activity ranged across pharmaceuticals, cloud infrastructure, cybersecurity, connected vehicles, medical AI and data-center power, as companies struck drug-development and commercialization deals, traded patent portfolios, expanded licensing pools and secured rights...To view the full article, register now.
Already a subscriber? Click here to view full article